Audentes Therapeutics, Inc. — Net Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3d64d765-1e06-4e8f-9af9-49903e406c98/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-128.8M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-005838 |
| FY 2017 | $-90.2M | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-005154 |
| FY 2016 | $-59.7M | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-004021 |
| FY 2015 | $-26.5M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-004021 |
| FY 2014 | $-10.8M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-004021 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).